Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Lupin Ltd. is an innovation led transnational pharmaceutical company, which engages in the manufacture of pharmaceutical products. It offers branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The firm caters to the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drug therapy, anti-tuberculosis, and cephalosporins industry segments. It operates through the following geographical segments: India, USA, Japan, and Others. The company was founded by Desh Bandhu Gupta in 1968 and is headquartered in Mumbai, India.

Pharmasyntez JSC is a private company headquartered in Irkutsk, Russia, also operating in Russia, that develops and manufactures pharmaceutical products.

Beijing Shengyiyao Technology Development Co., Ltd., established on 2001-04-02, The business scope includes the sale of third-class medical devices;Production of Class III medical devices;technology development,consult,Serve,transfer;software development;selling computers,Software and Auxiliary Equipment,medical instrumentsIkind,medical instrumentsIIkind;Import and export;Technology Import and Export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of Class III medical devices,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain.

Zaporizhzhia State Medical University (ZSMU) is a medical university in the small city of Zaporizhzhia, Ukraine.

Chengdu Baxter Wanhe Pharmaceutical Technology Co., Ltd., established on 2015-02-25, Business scope includes medical research and experimental development;Medical Technology Research,technology development,technology transfer,Technical Services(Does not include health care activities);Research and development of medical equipment and experimental equipment;Production(In the industrial industry, set up another branch for operation or choose another business site for operation),Sales of chemical products and raw materials(Free of Hazardous Chemicals,Monitoring of Chemicals and Precursor Chemicals);Sales of medical devices(first class only,The second type of project without permission);Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Shanghai Pulmonary Hospital, a subsidiary of Tongji University, is a Chinese company located in Shanghai that provides medical services.

Quegen Biotech Co., Ltd. operates as a fermentation company which develops and manufactures new bio-materials for cometic and functional foods. The firm specializes in fermentation for the production of bio-materials originated from microorganisms. The company was founded on May 8, 2006 and is headquartered in Siheung, South Korea.

Since World War II, antibiotics have been the most effective factor in longevity and population expansion. Today, loss of effective antibiotics threatens their medical institutions – antibiotic resistance is a serious problem already or will be within the decade. Doctors, in the US and UK, have reported that they now have less than a handful effective antibiotics for some pathogens. In the EU alone, infections with multidrug resistant bacteria cause around 25,000 deaths each year and the associated economic burden is immense. Still in today’s world, more infants and children are dying from pneumonia than from malaria.

Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD.

Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operations are carried out through the Pharmaceutical and Real Estate business segments. The Pharmaceutical segment mainly manufactures and sells pharmaceuticals, medical devices and agricultural chemicals. The Real Estate segment rents real estate related to Bunkyo Green Court. The company was founded in March 1917 and is headquartered in Tokyo, Japan.

Sun Rainforest (Xiamen) Biopharmaceutical Co., Ltd., established on 2015-09-06, Business scope includes engineering and technology research and experimental development;Medical Research and Experimental Development;Biopharmaceutical Manufacturing;Natural science research and experimental development;Cosmetic Manufacturing;Sanitary materials and medical supplies manufacturing;Manufacturing of chemical preparations;second,Retailing of Class III Medical Devices;Western medicine retail;Hazardous Chemical Retail;Manufacturing of other daily chemical products(Items not subject to permit approval);Manufacturing of other basic chemical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);Manufacturing of organic chemical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);Manufacturing of chemical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);Technology intermediary service;Biotechnology Extension Services;New material technology promotion service;Other technical promotion services;Other unspecified technology promotion and application service industries;Glue Manufacturing;Manufacture of other specialty chemical products(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);Biomass material manufacturing;Manufacture of High Performance Membrane Materials;Eco-environmental material manufacturing;Manufacture of other unlisted synthetic materials;Retailing of Class I Medical Devices;Retailing of cosmetics and hygiene products;Other unspecified retail trade(Items not subject to permit approval).

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research & development, manufacture, and sale of pharmaceutical products as well as veterinary medicines. Its products include active pharmaceutical ingredients and generic drugs. The company was founded in 1956 and is headquartered in Taizhou, China.

Aikedao Biotechnology Co., Ltd., established on 2016-09-09, Business scope includes fruit and vegetable cultivation,research and development,Technology Promotion;beverage manufacturing,Manufacture and sales of canned food,Aquatic products,soy products,meat products,bee products,dairy products,pastry,candy,biscuit,Manufacture and sales of candied fruit and other foods;Plant extracts,Healthy food,the tea,Manufacture and sale of cosmetics,vegetable,Processing and sales of fruits and nuts and agricultural and sideline products permitted by the policy;Processing of tinplate empty cans and self-sale of products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.

Science & Technology Corp. provides scientific, technical, and engineering services. The firm Specializes in defense chemical and biological research, test and evaluation, range support services, earth and space sciences, polar technologies, aerospace engineering and information systems engineering and support. The company was founded in 1979 and is headquartered in Hampton, VA.

Shanghai Public Health Clinical Center is a Chinese company located in Shanghai and ultimately controlled by the Government of China that operates hospital and provides education and training for disease control and prevention.